A Comparison of the Blood Glucose, Growth Hormone, and Cortisol Responses to Two Doses of Insulin (0.15 U/kg vs. 0.10 U/kg) in the Insulin Tolerance Test: A Single-Centre Audit of 174 Cases

Author:

Yeoh Phillip12ORCID,Dwyer Andrew A.34ORCID,Anghel Ella5ORCID,Bouloux Pierre M.167,Khoo Bernard168ORCID,Chew Shern19,Wernig Florian110ORCID,Carroll Paul111ORCID,Aylwin Simon J. B.112ORCID,Baldeweg Stephanie E.1813ORCID,Drake William114,Todd Jeannie110ORCID,Mangena Lindiwe1,Grossman Ashley115ORCID

Affiliation:

1. The London Clinic Centre for Endocrinology, London, UK

2. Florence Nightingale School of Nursing, Midwifery and Palliative Care, King’s College London, London, UK

3. Boston College William F. Connell School of Nursing, Chestnut Hill, MA, USA

4. Munn Center for Nursing Research, Massachusetts General Hospital, Boston, MA, USA

5. Boston College, Department of Measurement, Evaluation, Statistics and Assessment, Chestnut Hill, MA, USA

6. Royal Free London NHS Foundation Trust, London, UK

7. National Hospital for Neurology and Neurosurgery, London, UK

8. Division of Medicine, University College London, London, UK

9. OneWelbeck Endocrine Partners, London, UK

10. Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK

11. Guy's & St. Thomas' NHS Foundation Trust, London, UK

12. King's College Hospital NHS Foundation Trust, London, UK

13. Department of Diabetes & Endocrinology, University College London NHS Foundation Trust, London, UK

14. Barts Health NHS Trust, Saint Bartholomew's Hospital, London, UK

15. Centre for Endocrinology, Barts and the London School of Medicine, Queen Mary University of London, UK

Abstract

Objective. The insulin tolerance test (ITT) is the gold standard endocrine test used to assess the integrity of the growth hormone (GH) and cortisol axes. The ITT has potential risks, and severe hypoglycaemia may necessitate intravenous glucose rescue. There is no clear consensus as to the optimal insulin dose for the ITT. Therefore, we sought to compare the standard dose (0.15 U/kg) and a low-dose ITT (0.1 U/kg). Design. Single-centre audit of ITT data (2012–2021). Patients and Measurements. Patients who underwent an ITT to assess possible GH deficiency/adrenal insufficiency were included. Glucose, GH, and cortisol were measured at baseline and 30, 45, 60, 90, and 120 minutes following I.V. insulin bolus (0.15 U/kg or 0.10 U/kg). Results. Of the ITTs performed, only 3/177 (1.7%) did not achieve adequate hypoglycaemia (≤2.2 mmol/L) with a single insulin dose. In total, 174 patients (43.5 ± 12.1 yrs, mean ± standard deviation) were included for analysis (0.15 U/kg: n = 113, 0.10 U/kg: n = 61). All 174 subjects had adequate hypoglycaemia regardless of baseline fasting blood glucose level or insulin dose. Neither nadir glucose nor glucose delta (i.e., baseline minus nadir) differed between insulin doses. Trends in both cortisol and GH responses over time were similar between groups, and a greater proportion of patients receiving the standard dose had an adequate cortisol response (77/106 (72.6%) vs. 32/60 (53.3%), p = 0.01 ). The rates of glucose rescue did not differ in a subset of 79 patients, with on-demand glucose rescue in 4/35 (11%) for the standard dose and 2/44 (5%) for the low dose ( p = 0.25 ). Conclusions. Our results suggest that the low-dose ITT produces comparable glucose, cortisol, and GH responses to the higher dose. Given the risks associated with hypoglycaemia, the low dose appears to be preferable to the standard dose ITT in most circumstances.

Funder

London Clinic

Publisher

Hindawi Limited

Subject

Endocrine and Autonomic Systems,Endocrinology,Endocrinology, Diabetes and Metabolism

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3